论文部分内容阅读
以我国研制的抗肿瘤新药三尖杉酯碱为主的 HOAP 方案治疗急性非淋巴细胞白血病(ANLL)已取得肯定的疗效。但各地报告的完全缓解(CR)率相差很大。为改进我地区 ANLL 的治疗,现将我院1982年1月至1986年10月应用本方案治疗的32例总结如下:一般资料此期间共收治 ANLL89例,其中应用HOAP 方案治疗2个疗程以上可供疗效分析的共32例,其中复治3例。男22例,女10例,年龄22—71岁。按1980年全国白血病分类分型
To our country developed anti-tumor drugs harringtonine-based HOAP regimen for the treatment of acute non-lymphocytic leukemia (ANLL) has achieved a positive effect. However, the rates of complete remission (CR) reported vary widely across regions. To improve the treatment of ANLL in my area, now our hospital from January 1982 to October 1986 the application of this regimen of 32 cases are summarized as follows: General information during this period were treated ANLL89 cases, including the application of HOAP regimen for more than 2 courses For the efficacy analysis of a total of 32 cases, including retreatment in 3 cases. 22 males and 10 females, aged 22-71 years. By 1980 National Leukemia classification